🇪🇸 Spanish PM Pedro Sánchez defends rejecting a 5% of GDP defense target to protect social spending He says Spain rejected the target to keep prioritizing education, healthcare, and pensions. Spain only recently reached around 2% of GDP in defense spe
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report is about defense and pharma and health.
Directly affected
- No company is named in this report.
Indirectly affected
- ITA iShares U.S. Aerospace & Defense ETF+1.1% 30d
iShares U.S. Aerospace & Defense ETF: it holds defense and aerospace contractors. Linked by “defense” (defense) in this story.
- XAR SPDR S&P Aerospace & Defense ETF-4.4% 30d
SPDR S&P Aerospace & Defense ETF: it holds defense and aerospace contractors. Linked by “defense” (defense) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- EWP iShares MSCI Spain ETF-0.9% 6d
iShares MSCI Spain ETF holds stocks listed in Spain, which this story is about (“spain”).
- LLY Eli Lilly and+15.5% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- JNJ Johnson & Johnson+0.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- PFE Pfizer+4.0% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- MRK Merck+3.5% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ITA | +3.67% | +2.77% | base | after close | after close | after close | after close |
| XAR | +2.91% | +0.53% | base | after close | after close | after close | after close |
| XLV | -0.10% | +2.63% | base | after close | after close | after close | after close |
| EWP | -1.23% | +2.08% | base | after close | after close | after close | after close |
| LLY | +4.21% | +4.67% | base | after close | after close | after close | after close |
| JNJ | -2.08% | +0.00% | base | after close | after close | after close | after close |
| PFE | +4.51% | +4.78% | base | after close | after close | after close | after close |
| MRK | +1.15% | +2.46% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
🇪🇸 Spanish PM Pedro Sánchez defends rejecting a 5% of GDP defense target to protect social spending He says Spain rejected the target to keep prioritizing education, healthcare, and pensions. Spain only recently reached around 2% of GDP in…
Source: X
This story
| Company | When | Move | Status |
|---|---|---|---|
| EWP | three days earlier | +2.08% | final price |
| EWP | five days earlier | -1.23% | final price |
| ITA | three days earlier | +2.77% | final price |
| ITA | five days earlier | +3.67% | final price |
| JNJ | three days earlier | 0.00% | final price |
| JNJ | five days earlier | -2.08% | final price |
| LLY | three days earlier | +4.67% | final price |
| LLY | five days earlier | +4.21% | final price |
| MRK | three days earlier | +2.46% | final price |
| MRK | five days earlier | +1.15% | final price |
| PFE | three days earlier | +4.78% | final price |
| PFE | five days earlier | +4.51% | final price |
| XAR | three days earlier | +0.53% | final price |
| XAR | five days earlier | +2.91% | final price |
| XLV | three days earlier | +2.63% | final price |
| XLV | five days earlier | -0.10% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 64 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 38 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 43 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 60 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 64 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 78 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 44 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 80 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“🇪🇸 Spanish PM Pedro Sánchez defends rejecting a 5% of GDP defense target to protect social spending He says Spain rejected the target to keep prioritizing education, healthcare, and pensions. Spain only recently reached around 2% of GDP in defense spe” scores 12 out of 100. The score uses 1 sources.